Skip to main content

FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV

The Food and Drug Administration on Monday approved AstraZeneca and Sanofi’s shot that protects infants and toddlers against respiratory syncytial virus, which is the leading cause of hospitalization among babies in the U.S.

Media Miss by the Right

See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below.

Learn more about this data

Left 19%

Center 71%

Right 10%

Bias Distribution

Click to see headlines

Far
Left

+0

Far
Right

+0

Untracked Bias

95 other sources covering this story

Total News Sources

95

Leaning Left

15

Center

57

Leaning Right

8

Last Updated

12 months ago

Bias Distribution Powered by Ground News